BioCentury | Jul 20, 2009
Company News

Nuon management update

...formerly CBO at Anacor Pharmaceuticals Inc. ; and Tito Serafini as CSO, formerly VP at Renovis Inc....
BioCentury | Jul 6, 2009
Finance

Restructuring Watch

...consolidation of its European facilities and the wind down of operations at its U.S. subsidiary Renovis Inc....
BioCentury | Jun 8, 2009
Finance

Managing Austerity

...He also closed the company's U.S. operation, which it got via its 2007 acquisition of Renovis Inc....
BioCentury | May 11, 2009
Company News

Evotec neurology news

...at its U.S. subsidiary Renovis Inc. Evotec, which acquired Renovis in 2007, will continue to develop Renovis'...
BioCentury | Aug 11, 2008
Clinical News

VRI antagonist: Phase I started

...ascending-dose Phase I trial in healthy volunteers with an oral VR1 antagonist . Pfizer and Renovis Inc....
BioCentury | Jun 30, 2008
Strategy

Pfizer fleshing out its model

...of the restructuring, Chairman and CEO Jeffrey Kindler approached Goodman, the president and CEO of Renovis Inc....
BioCentury | May 22, 2008
Targets & Mechanisms

So FAAH, So Good, Maybe

...^ chlorpyrifos is one of the compounds." FAAH inhibitors Fabien Vincent, senior scientist at the Renovis Inc....
...told SciBX . Evotec gained an FAAH inhibitor program when it completed its acquisition of Renovis...
BioCentury | May 12, 2008
Finance

Ebb & Flow

...after the neurology, chemistry and high throughput screening company said it completed its acquisition of Renovis...
BioCentury | May 12, 2008
Company News

Evotec, Renovis deal

...Evotec completed its previously announced acquisition of Renovis for about 35 million shares valued at E58.8...
...before the deal closed (see BioCentury, Sept. 24, 2007). Evotec AG (Xetra:EVT; NASDAQ:EVTC), Hamburg, Germany Renovis Inc....
BioCentury | Mar 24, 2008
Product Development

Neurocognitive mind-field

...running into Phase III difficulties in late-stage testing include both a neuroprotectant, NXY-059 (Cerovive) from Renovis Inc....
...NYSE:NVS; SWX:NOVN), Basel, Switzerland Paion AG (FSE:PA8), Aachen, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Renovis Inc....
Items per page:
1 - 10 of 152
BioCentury | Jul 20, 2009
Company News

Nuon management update

...formerly CBO at Anacor Pharmaceuticals Inc. ; and Tito Serafini as CSO, formerly VP at Renovis Inc....
BioCentury | Jul 6, 2009
Finance

Restructuring Watch

...consolidation of its European facilities and the wind down of operations at its U.S. subsidiary Renovis Inc....
BioCentury | Jun 8, 2009
Finance

Managing Austerity

...He also closed the company's U.S. operation, which it got via its 2007 acquisition of Renovis Inc....
BioCentury | May 11, 2009
Company News

Evotec neurology news

...at its U.S. subsidiary Renovis Inc. Evotec, which acquired Renovis in 2007, will continue to develop Renovis'...
BioCentury | Aug 11, 2008
Clinical News

VRI antagonist: Phase I started

...ascending-dose Phase I trial in healthy volunteers with an oral VR1 antagonist . Pfizer and Renovis Inc....
BioCentury | Jun 30, 2008
Strategy

Pfizer fleshing out its model

...of the restructuring, Chairman and CEO Jeffrey Kindler approached Goodman, the president and CEO of Renovis Inc....
BioCentury | May 22, 2008
Targets & Mechanisms

So FAAH, So Good, Maybe

...^ chlorpyrifos is one of the compounds." FAAH inhibitors Fabien Vincent, senior scientist at the Renovis Inc....
...told SciBX . Evotec gained an FAAH inhibitor program when it completed its acquisition of Renovis...
BioCentury | May 12, 2008
Finance

Ebb & Flow

...after the neurology, chemistry and high throughput screening company said it completed its acquisition of Renovis...
BioCentury | May 12, 2008
Company News

Evotec, Renovis deal

...Evotec completed its previously announced acquisition of Renovis for about 35 million shares valued at E58.8...
...before the deal closed (see BioCentury, Sept. 24, 2007). Evotec AG (Xetra:EVT; NASDAQ:EVTC), Hamburg, Germany Renovis Inc....
BioCentury | Mar 24, 2008
Product Development

Neurocognitive mind-field

...running into Phase III difficulties in late-stage testing include both a neuroprotectant, NXY-059 (Cerovive) from Renovis Inc....
...NYSE:NVS; SWX:NOVN), Basel, Switzerland Paion AG (FSE:PA8), Aachen, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Renovis Inc....
Items per page:
1 - 10 of 152